In amyotrophic lateral sclerosis (ALS) associated with mutations in the SOD1 gene, a protein called S100A6 may contribute to…
Articles by Michela Luciano, PhD
Clene Nanomedicine has submitted an application to the U.S. Food and Drug Administration (FDA) seeking accelerated approval of its experimental…
The ALS Association has launched a nationwide campaign to help people with amyotrophic lateral sclerosis (ALS) fight insurance…
An artificial intelligence-powered communication app helps people with amyotrophic lateral sclerosis (ALS) and other conditions that affect speech keep…
Otsuka Pharmaceutical’s experimental therapy ulefnersen improved a combined measure of function and survival compared with a placebo in people…
A newer set of diagnostic criteria for amyotrophic lateral sclerosis (ALS) was significantly more sensitive at identifying people with…
Stem cell therapies are generally safe and well tolerated in people with amyotrophic lateral sclerosis (ALS), and preliminary evidence…
Neurosense Therapeutics plans to seek Health Canada approval by the end of the year for PrimeC, its experimental oral…
People whose jobs expose them to pesticides may be more likely to develop amyotrophic lateral sclerosis (ALS) than workers…
Editor’s note: This story includes discussion of suicide. If you or someone you know needs help, the national suicide and…